Genetic Variations in Sex Steroid-Related Genes as Predictors of Serum Estrogen Levels in Men
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
CONTEXT: The risk of many conditions, including prostate cancer, breast cancer, and osteoporosis, is associated with serum levels of sex steroids. OBJECTIVE: The aim of the study was to identify genetic variations in sex steroid-related genes that are associated with serum levels of estradiol (E2) and/or testosterone in men. DESIGN: Genotyping of 604 single nucleotide polymorphisms in 50 sex steroid-related candidate genes was performed in the Gothenburg Osteoporosis and Obesity Determinants (GOOD) study (n = 1041 men; age, 18.9 +/- 0.6 yr). Replications of significant associations were performed in the Osteoporotic Fractures in Men (MrOS) Sweden study (n = 2568 men; age, 75.5 +/- 3.2 yr) and in the MrOS US study (n = 1922 men; age, 73.5 +/- 5.8 yr). Serum E2, testosterone, and estrone (E1) levels were analyzed using gas chromatography/mass spectrometry. RESULTS: The screening in the GOOD cohort identified the single nucleotide polymorphism rs2470152 in intron 1 of the CYP19 gene, which codes for aromatase, responsible for the final step of the biosynthesis of E2 and E1, to be most significantly associated with serum E2 levels (P = 2 x 10(-6)). This association was confirmed both in the MrOS Sweden study (P = 9 x 10(-7)) and in the MrOS US study (P = 1 x 10(-4)). When analyzed in all subjects (n = 5531), rs2470152 was clearly associated with both E2 (P = 2 x 10(-14)) and E1 (P = 8 x 10(-19)) levels. In addition, this polymorphism was modestly associated with lumbar spine BMD (P < 0.01) and prevalent self-reported fractures (P < 0.05). CONCLUSIONS: rs2470152 of the CYP19 gene is clearly associated with serum E2 and E1 levels in men.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., et al. (2007) · Science · doi:10.1126/science.1142358 · Cited by 2,843 · cited 1×
“Enzymes in synthesis AKR1C3((1)), CYP 17((5)), CYP19((6)), HSD17B (types 1((23)), 2((24)), 3((25)), 4((26)), 6((27)), 7((28)), 8((29)), 10((30)), 12((31)), and 13((32))), HSD3B (types 1((33)) and 2((34))), 5 -reductase type-1((41)), 5 -reductase type 2((42)) Enzymes in degradation COMT((4)), CYP1A1((7)), CYP1A2((8)),…”
Estrogen Resistance Caused by a Mutation in the Estrogen-Receptor Gene in a Man
Smith, E. P., Boyd, J., Frank, G. R., Takahashi, H., Cohen, R. M., Specker, B., Williams, T. C., Lubahn, D. B., & Korach, K. S. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410203311604 · Cited by 2,471 · cited 2×
“Enzymes in synthesis AKR1C3((1)), CYP 17((5)), CYP19((6)), HSD17B (types 1((23)), 2((24)), 3((25)), 4((26)), 6((27)), 7((28)), 8((29)), 10((30)), 12((31)), and 13((32))), HSD3B (types 1((33)) and 2((34))), 5 -reductase type-1((41)), 5 -reductase type 2((42)) Enzymes in degradation COMT((4)), CYP1A1((7)), CYP1A2((8)),…”
Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes
Zeggini, E., Weedon, M. N., Lindgren, C. M., Frayling, T. M., Elliott, K. S., Lango, H., Timpson, N. J., Perry, J. R. B., Rayner, N. W., Freathy, R. M., et al. (2007) · Science · doi:10.1126/science.1142364 · Cited by 2,194 · cited 2×
“Enzymes in synthesis AKR1C3((1)), CYP 17((5)), CYP19((6)), HSD17B (types 1((23)), 2((24)), 3((25)), 4((26)), 6((27)), 7((28)), 8((29)), 10((30)), 12((31)), and 13((32))), HSD3B (types 1((33)) and 2((34))), 5 -reductase type-1((41)), 5 -reductase type 2((42)) Enzymes in degradation COMT((4)), CYP1A1((7)), CYP1A2((8)),…”
Genomewide Association Analysis of Coronary Artery Disease
Samani, N. J., Erdmann, J., Hall, A. S., Hengstenberg, C., Mangino, M., Mayer, B., Dixon, R. J., Meitinger, T., Braund, P., Wichmann, H.-E., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072366 · Cited by 2,044 · cited 2×
“Enzymes in synthesis AKR1C3((1)), CYP 17((5)), CYP19((6)), HSD17B (types 1((23)), 2((24)), 3((25)), 4((26)), 6((27)), 7((28)), 8((29)), 10((30)), 12((31)), and 13((32))), HSD3B (types 1((33)) and 2((34))), 5 -reductase type-1((41)), 5 -reductase type 2((42)) Enzymes in degradation COMT((4)), CYP1A1((7)), CYP1A2((8)),…”
Sex Steroids and the Construction and Conservation of the Adult Skeleton
Riggs, B. L., Khosla, S., & Melton, L. J. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.3.0465 · Cited by 1,846
Morishima, A., Grumbach, M. M., Simpson, E. R., Fisher, C., & Qin, K. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.12.8530621 · Cited by 1,416
Stacey, S. N., Manolescu, A., Sulem, P., Rafnar, T., Gudmundsson, J., Gudjonsson, S. A., Masson, G., Jakobsdottir, M., Thorlacius, S., Helgason, A., et al. (2007) · Nature Genetics · doi:10.1038/ng2064 · Cited by 786
Vanderschueren, D., Vandenput, L., Boonen, S., Lindberg, M. K., Bouillon, R., & Ohlsson, C. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0003 · Cited by 717
Self-citationWang, C., Catlin, D. H., Demers, L. M., Starcevic, B., & Swerdloff, R. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031287 · Cited by 580 · cited 3×
“related polymorphisms on serum sex steroid levels, except the large-sized Swedish SHBG study (20), have investigated serum E2 and/or T levels using immunochemical assays with a questionable specificity at lower concentrations (21, 22).”
Khosla, S. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.7.2266 · Cited by 447
Mellström, D., Johnell, O., Ljunggren, Ö., Eriksson, A.-L., Lorentzon, M., Mallmin, H., Holmberg, A., Redlund-Johnell, I., Orwoll, E., & Ohlsson, C. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060110 · Cited by 337 · cited 2×
“Study subjects of the population-based MrOS Sweden study (n 3014; men aged 69–81 yr) were randomly identified using national population registers, contacted, and asked to participate (25).”
Self-citationRaven, G., de Jong, F. H., Kaufman, J.-M., & de Ronde, W. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0462 · Cited by 134 · cited 1×
“High levels of E2 are known to lower T levels via a negative feedback on LH secretion in the experimental situation ( 33 ).”
Heritability of plasma sex hormones and hormone binding globulin in adult male twins
Ring, H. Z., Lessov, C. N., Reed, T., Marcus, R., Holloway, L., Swan, G. E., & Carmelli, D. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1025 · Cited by 117 · cited 2×
“Enzymes in synthesis AKR1C3((1)), CYP 17((5)), CYP19((6)), HSD17B (types 1((23)), 2((24)), 3((25)), 4((26)), 6((27)), 7((28)), 8((29)), 10((30)), 12((31)), and 13((32))), HSD3B (types 1((33)) and 2((34))), 5 -reductase type-1((41)), 5 -reductase type 2((42)) Enzymes in degradation COMT((4)), CYP1A1((7)), CYP1A2((8)),…”
Eriksson, A. L., Lorentzon, M., Mellström, D., Vandenput, L., Swanson, C., Andersson, N., Hammond, G. L., Jakobsson, J., Rane, A., Orwoll, E. S., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0679 · Cited by 101 · cited 3×
“Furthermore, we have shown that an SHBG promoter polymorphism is clearly associated not only with serum SHBG but also serum T in two large (n 3988) male Swedish cohorts (20), and that the H(268)Y polymorphism of UGT2B7 is associated with serum T levels in young adult Swedish men (15).”
Self-citationVandenput, L., Labrie, F., Mellström, D., Swanson, C., Knutsson, T., Peeker, R., Ljunggren, Ö., Orwoll, E., Eriksson, A. L., Damber, J.-E., et al. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.061018 · Cited by 71 · cited 3×
“The aim of the present study was to screen for most of the common genetic variation in 50 sex steroid-related genes to identify genetic variants that, in a reproducible manner, have an impact on serum E2 and/or T levels in men using three large (n 5531) well-characterized male cohorts in which serum sex steroids have…”
Self-citation
Cited by
Flores, R., Shi, J., Fuhrman, B., Xu, X., Veenstra, T. D., Gail, M. H., Gajer, P., Ravel, J., & Goedert, J. J. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-253 · Cited by 615
Sex Steroid Actions in Male Bone
Vanderschueren, D., Laurent, M. R., Claessens, F., Gielen, E., Lagerquist, M. K., Vandenput, L., Börjesson, A. E., & Ohlsson, C. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1024 · Cited by 327
Self-citationInfluence of Sex Hormones on Cancer Progression
Folkerd, E. J., & Dowsett, M. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.4290 · Cited by 229
Kallak, T. K., Hellgren, C., Skalkidou, A., Sandelin-Francke, L., Ubhayasekhera, K., Bergquist, J., Axelsson, O., Comasco, E., Campbell, R. E., & Sundström Poromaa, I. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0207 · Cited by 70
Metadata
- Authors
- Eriksson, A. L., Lorentzon, M., Vandenput, L., Labrie, F., Lindersson, M., Syvänen, A.-C., Orwoll, E. S., Cummings, S. R., Zmuda, J. M., Ljunggren, O., Karlsson, M. K., Mellström, D., & Ohlsson, C.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2009-03-01
- Volume
- 94
- Issue
- 3
- Pages
- 1033-1041
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2143377924
- Cited by
- 65
- References
- 15
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.